The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

First experience with the Impella Recover® LP 2.5 micro axial pump in patients with cardiogenic shock or undergoing high-risk revascularisation

EuroIntervention 2006;2:84-90 - DOI10.4244/EIJV2I1A14.

1. Department of Cardiology, UH Leuven, Belgium; 2. Department of Cardiac Surgery, UH Leuven, Belgium; 3. Department of Medical Statistics, RWTH-Aachen, Germany; 4. Department of Cardiac Surgery, UH Maastricht, The Netherlands; 5. Department of Cardiology

Aim: To study the feasibility, safety and efficacy of the Recover® LP 2.5 assist device in patients scheduled for high risk off-pump coronary bypass surgery, percutaneous coronary in

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Use of Impella Recover® LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings